These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
574 related articles for article (PubMed ID: 19207660)
21. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study. Mazzotta A; Esposito M; Costanzo A; Chimenti S Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444 [TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor-alpha blockade and the risk of vasculitis. Guillevin L; Mouthon L J Rheumatol; 2004 Oct; 31(10):1885-7. PubMed ID: 15468348 [No Abstract] [Full Text] [Related]
23. Do TNF-blockers reduce or induce uveitis? Cobo-Ibáñez T; del Carmen Ordóñez M; Muñoz-Fernández S; Madero-Prado R; Martín-Mola E Rheumatology (Oxford); 2008 May; 47(5):731-2. PubMed ID: 18346974 [No Abstract] [Full Text] [Related]
24. Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-alpha blocking agents: two cases. Lourari S; Prey S; Livideanu C; Jamard B; Lamant L; Cantagrel A; Paul C J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):967-8. PubMed ID: 19192017 [No Abstract] [Full Text] [Related]
25. Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors. Deng A; Harvey V; Sina B; Strobel D; Badros A; Junkins-Hopkins JM; Samuels A; Oghilikhan M; Gaspari A Arch Dermatol; 2006 Feb; 142(2):198-202. PubMed ID: 16490847 [TBL] [Abstract][Full Text] [Related]
26. Anti-tumor necrosis factor alpha therapy in psoriatic arthritis and psoriasis. Girolomoni G; Abeni D Arch Dermatol; 2001 Jun; 137(6):784-5. PubMed ID: 11405771 [No Abstract] [Full Text] [Related]
27. Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial. Prinz JC; Fitzgerald O; Boggs RI; Foehl J; Robertson D; Pedersen R; Molta CT; Freundlich B J Eur Acad Dermatol Venereol; 2011 May; 25(5):559-64. PubMed ID: 20840349 [TBL] [Abstract][Full Text] [Related]
28. Paradoxical psoriatic arthritis in a patient with rheumatoid arthritis treated by TNFα blocker. Villani AP; Weiler L; Jullien D; Chapurlat R; Confavreux C Joint Bone Spine; 2014 Oct; 81(5):455-6. PubMed ID: 24561024 [No Abstract] [Full Text] [Related]
33. BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology. Keat A; Barkham N; Bhalla A; Gaffney K; Marzo-Ortega H; Paul S; Rogers F; Somerville M; Sturrock R; Wordsworth P; Rheumatology (Oxford); 2005 Jul; 44(7):939-47. PubMed ID: 15901904 [No Abstract] [Full Text] [Related]
34. Henoch-Schönlein purpura after etanercept therapy for psoriasis. Lee A; Kasama R; Evangelisto A; Elfenbein B; Falasca G J Clin Rheumatol; 2006 Oct; 12(5):249-51. PubMed ID: 17023811 [TBL] [Abstract][Full Text] [Related]
35. Successful treatment of psoriasis and psoriatic arthritis with etanercept and methotrexate in a patient newly unresponsive to infliximab. Strober BE Arch Dermatol; 2004 Mar; 140(3):366. PubMed ID: 15023789 [No Abstract] [Full Text] [Related]
36. Psoriatic onychopachydermoperiostitis: improvement with etanercept. Dans M; Hivnor C; van Voorhees AS Br J Dermatol; 2005 Oct; 153(4):858-9. PubMed ID: 16181482 [No Abstract] [Full Text] [Related]
37. Psoriasiform and pustular eruption induced by etanercept and infliximab. Kuhara T; Watanabe D; Iwahori Y; Tamada Y; Yamamura M; Matsumoto Y Eur J Dermatol; 2009; 19(4):388-9. PubMed ID: 19467963 [No Abstract] [Full Text] [Related]